(Q33761151)

29 July 2017

title

Are adult patients more tolerant of treatment risks than parents of juvenile patients? (English)

1 reference

29 July 2017

F Reed Johnson

1

1 reference

29 July 2017

Semra Ozdemir

2

1 reference

29 July 2017

Carol Mansfield

3

1 reference

29 July 2017

Steven Hass

4

1 reference

29 July 2017

Corey A Siegel

5

1 reference

29 July 2017

Bruce E Sands

6

1 reference

29 July 2017

publication date

26 September 2008

1 reference

29 July 2017

1 reference

29 July 2017

volume

29

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

121-136

1 reference

Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Stabilization wedges: solving the climate problem for the next 50 years with current technologies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Using discrete choice experiments to value health care programmes: current practice and future research reflections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Advances in the management of Crohn's disease: economic and clinical potential of infliximab.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Cost-benefit analysis: an ethical critique

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2847437

Measuring patient preferences by willingness to pay to avoid: the case of acute otitis media

30 October 2018

1 reference

12 December 2020

A willingness-to-pay assessment of parents' preference for shorter duration treatment of acute otitis media in children

1 reference

12 December 2020

Drug safety reform at the FDA--pendulum swing or systematic improvement?

1 reference

12 December 2020

The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial

1 reference

12 December 2020

1 reference

12 December 2020

10.1111/J.1539-6924.2008.01135.X

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference